Asian Journal of Psychiatry
Volume 2, Issue 3 , Pages 93-94 , October 2009

Importance of metabolic syndrome for South Asians

  • Rohan Ganguli, M.D., F.R.C.P.(C)

      Affiliations

    • Corresponding Author InformationTel.: +1 416 535 8501; fax: +1 416 583 3485.

References 

  1. Alberti KG, Zimmet P, Shaw J IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–1062
  2. Cappuccio FP, Barbato A, Kerry SM. Hypertension, diabetes and cardiovascular risk in ethnic minorities in the UK. British Journal of Diabetes & Vascular Disease. 2003;3:286–293
  3. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438
  4. Khattar RS, Swales JD, Senior R, Lahiri A. Racial variation in cardiovascular morbidity and mortality in essential hypertension. Heart. 2000;83:267–271
  5. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J. Assoc. Phys. India. 2009;57:163–170
  6. Misra A, Rama Devi J, Nidhi K, Sharma R, Pandey RM. High prevalence of obesity, dyslipidemia and diabetes in urban slum population of Northern India. Diab. Res. Clin. Pract. 2000;50(Suppl. 1):S351
  7. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 2008;93:S9–S30
  8. Newcomer J, Haupt D. The metabolic effects of antipsychotic medications. Can. J. Psychiatry. 2006;51:480–491
  9. Ramachandran A, Snehalatha C, Simon M, Mukesh B, Bhaskar AD, Vijay V. The Indian diabetes prevention program shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance. Diabetologica. 2006;49:289–297
  10. Ramachandran A, Snehalatha C, Simon M, Zhang P, Annasami Y. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian-Indians. Diabetes Care. 2007;30:25548–32552
  11. Reddy KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics, and directions for public health action. Public Health Nutr. 2002;5:231–237
  12. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap widening. Arch. Gen. Psychiatry. 2007;64:1123–1131
  13. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004;27:1182–1186

PII: S1876-2018(09)00062-8

doi: 10.1016/j.ajp.2009.08.002

Asian Journal of Psychiatry
Volume 2, Issue 3 , Pages 93-94 , October 2009

Article Tools